A postdoctoral position is available starting in the winter or spring of 2021 in the Laboratory of Dr. David Brooks at the Princess Margaret Cancer Center (PMCC). The postdoctoral fellow will be a part of the Tumor Immunotherapy Program at the PMCC and the University of Toronto Department of Immunology in Toronto, Ontario. The fellow will work to understand the opposing stimulatory and suppressive mechanisms of type I interferon mediated immune regulation in chronic virus infections. This project will take advantage of new approaches we have developed to uncover the single-cell and spatial mechanisms of how type I interferons skew T cell diversity in chronic infections in mice and humans, and how to target these factors to modulate subsequent responses to immunotherapy. The postdoc will work alongside a great, and growing, laboratory Team investigating immune regulation in chronic viral and mycobacterial infections and in cancer.
To be considered, the Candidate must have a strong background in molecular or cellular immunology, with a proven track-record of success in the immunologic sciences.
Applicant must be near-graduating or recently have been awarded PhD or MD/PhD degree within the last year.
Candidates must be highly motivated, possess excellent communication skills, detail-oriented and organized, and a strong record of scientific accomplishments, including publications in peer-reviewed journals and scientific presentations.
Salary: Highly competitive
Applicants should respond by email to Dr. David Brooks with (1) a curriculum vitae and (2) a brief description of research interests.
Lab Website: http://www.uhnresearch.ca/researcher/david-brooks
The Princess Margaret Cancer Center (PMCC) is one of the largest cancer facilities in the world located in the heart of the vibrant and diverse city of Toronto, Canada. Through its commitment to research, education and innovation, PMCC stands on the frontiers of medical and experimental oncology. The scientific excellence of its internationally recognized researchers and cutting-edge research infrastructure rank the PMCC amongst the top five cancer centers in the world.